Tetra Bio-Pharma Appoints Aphria CFO as Chair of Audit Committee

Tetra Bio-Pharma (TSXV:TBP; OTCQB:TBPMF) announced the appointment of Aphria (TSX:APH; OTC:APHQF) Chief Financial Officer Carl Merton, as Chair of Tetra’s Audit Committee.

As quoted in the press release:

In addition to his extensive financial background, Mr. Merton is a Chartered Accountant and has served as a past Chair of both the CICBV and the International Association of Professional Business Valuators. Mr. Merton is currently a member of the Board of Directors and Chair of the Audit Committee of Motor City Community Credit Union.

Mr. Merton has served on the Tetra Board since 2016 and brings over 20 years of financial and business experience to the Audit Committee. He replaces Mr. Robert Brouillette, whose resignation was accepted immediately upon the Board becoming aware that a decision had been rendered by a professional regulatory organization against Mr. Brouillette in relation to professional activities unrelated to his responsibilities as a director of Tetra.

Click here to read the full press release.

Source: www.marketwired.com